Banner MD Anderson Cancer Center at Banner Gateway Medical Center

Sorting 2 by

Accepting patients

APG-115

A Phase Ib/II Study of APG-115 Alone or in Combination With Azacitidine in Patients With Relapse/Refractory AML, CMML or MDS
Learn more
  • MDM2 Inhibitor
  • Phase 1/2

Not yet accepting

Lisaftoclax

A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).
Learn more
  • BCL-2 Inhibitor
  • Placebo
  • Randomization
  • Phase 3